Available to mentor
I am a pediatric neurologist and neuroimmunologist who specializes in seeing pediatric patients with neuroimmunological disorders, such as demyelinating diseases and others. I completed fellowship training in multiple sclerosis and neuroimmunological disorders at the University of Michigan and a three month observership at the Children's Hospital of Philadelphia in their Pediatric Neuroimmunology department.
Types of demyelinating diseases include:
Multiple sclerosis (MS)
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Transverse Myelitis
Optic Neuritis
Acute Disseminated Encephalomyelitis (ADEM)
Clinically Isolated Syndrome (CIS)
Radiologically Isolated Syndrome (RIS)
Outside of demyelinating disorders, there are other neuro-immunological disorders such as:
Autoimmune Encephalitis
Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS/OMS)
Central Nervous System Vasculitis/Primary Angiitis of the Central Nervous System (PACNS)
Lupus Cerebritis
Neurosarcoidosis
Hashimoto’s Encephalopathy
Neuro-Behcet’s
Neuro-Sjogren’s
Acute Flaccid Myelitis (This is an infectious disorder, not a neuro-immune disorder, but the Pediatric Neuroimmunology Clinic is still typically involved in the evaluation and management of this disorder.)
University of Michigan Pediatric Neuroimmunology Disorders Site
-
Pediatric Multiple Sclerosis and Neuroinflammatory Disorders ObservershipChildren's Hospital of Philadelphia, Pediatric Multiple Sclerosis and Neuroinflammatory Disorders, 2021
-
Multiple Sclerosis and Neuroimmunology FellowshipUniversity of Michigan, Ann Arbor, MI, 2021
-
Chief Resident in Pediatric NeurologyUniversity of Michigan, Ann Arbor, MI, 2020
-
Pediatric Neurology ResidencyUniversity of Michigan, Ann Arbor, 2020
-
MDWayne State University School of Medicine, 540 E Canfield St, 2015
-
BAWayne State University, Detroit, 2011
I am interested in investigating the utility of testing for neuro-immunological disorders as well as treatments for neuro-immunological disorders and epilepsy in pediatric patients.
-
Yang J, Hamade M, Wu Q, Wang Q, Axtell R, Giri S, Mao-Draayer Y. Int J Mol Sci, 2022 May 24; 23 (11):Journal ArticleCurrent and Future Biomarkers in Multiple Sclerosis.
DOI:10.3390/ijms23115877 PMID: 35682558 -
Hamade M, Mohan S, Cartwright K. 2022 Jan 3;Additional ScholarshipUpdated institutional clinical practice guideline regarding evaluation and treatment of pediatric autoimmune encephalitis
-
Braley T. 2020 Oct 14;Additional ScholarshipCognitive Behavioral Therapy, Modafinil, or Both for Multiple Sclerosis Fatigue NCT03621761
-
Braley T, Alschuler K, Ehde D, Little R, Zhai Y, von Geldern G, Chervin R, Conroy D, Valentine T, Ng YT, Romeo A, LaRocca N, Hamade M, Jordan A, Singh M, Segal B, Kratz A. The Lancet Neurology,Journal ArticleA Comparative Effectiveness Trial of Cognitive Behavioral Therapy, Modafinil, and Combination Therapy for Fatigue in Multiple Sclerosis: the COMBO-MS Trial
-
Patel N, Mackenzie S, Hamade M, Shellhaas R, McNamara N, Fedak Romanowski E. 2020 Oct 1;Proceeding / Abstract / PosterQuality Improvement Initiatives to Increase Administration of Folic Acid Supplementation for Adolescent Girls Prescribed Antiseizure Medication.